Skip to main content
Clinical Trials/EUCTR2020-005682-13-NL
EUCTR2020-005682-13-NLActive, not recruitingPhase 1

Exploratory study into age-related immunological differences related to immunogenicity in influenza vaccination and herpes zoster vaccination - INFLUENZA-SHINGRIX

Radboudumc0 sites140 target enrollmentStarted: January 5, 2021Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Radboudumc
Enrollment
140

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Age between 18-35 years old OR age =65 years old
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

Exclusion Criteria

  • Known allergy to (components of) the influenza or herpes zoster vaccine
  • Immunocompromised subjects
  • Previous herpes zoster vaccination in the last year
  • Receipt of any vaccination 1 month prior to the start of the study or plans to receive any other vaccination until the last study visit
  • Chronic use of systemic drugs other than oral contraceptives
  • Use of NSAIDS less than 4 weeks prior to the start of the study
  • Acute or active illness within two weeks prior to the start of the study
  • Pregnant, breastfeeding or planning to become pregnant within the study period

Investigators

Sponsor
Radboudumc

Similar Trials